Profile - To The Moon

Sarohiwal

Entry level person in stocks & options in 2025

Posts · 100Posts · 100
Following · 0Following · 0
Followers · 0Followers · 0

- SarohiwalSarohiwal
  ·12-03 16:13
  $SOXS 20260220 3.0 PUT$
  14 Comment
  1
  Share
  Report
- SarohiwalSarohiwal
  ·12-03 16:13
  $SOXS 20260220 3.0 PUT$
  0 Comment
  Like
  Share
  Report
- SarohiwalSarohiwal
  ·12-03 16:12
  $SOXS 20260220 3.0 PUT$
  0 Comment
  Like
  Share
  Report
- SarohiwalSarohiwal
  ·12-02
  $MU 20260618 135.0 PUT$
  0 Comment
  Like
  Share
  Report
- SarohiwalSarohiwal
  ·12-01
  Share your opinion about this news…
  Philips launches Verida, world’s first detector-based spectral CT powered by breakthrough AI, to advance diagnostic precision
  Philips Verida spectral CT system, straight-on view. Philips Verida spectral CT system, straight-on view
  Philips launches Verida, world’s first detector-based spectral CT powered by breakthrough AI, to advance diagnostic precision
  1 Comment
  Like
  Share
  Report
- SarohiwalSarohiwal
  ·12-01
  Excellent product, will Help lots of patients across the world for accurate diagnostics.
  Philips launches Verida, world’s first detector-based spectral CT powered by breakthrough AI, to advance diagnostic precision
  Philips Verida spectral CT system, straight-on view. Philips Verida spectral CT system, straight-on view
  Philips launches Verida, world’s first detector-based spectral CT powered by breakthrough AI, to advance diagnostic precision
  21 Comment
  Like
  Share
  Report
- SarohiwalSarohiwal
  ·11-30
  Thanks for sharing, I already invested in this SRS, this is really good investment options
  91 Comment
  Like
  Share
  Report
- SarohiwalSarohiwal
  ·11-29
  $AMD 20260717 150.0 PUT$
  16 Comment
  1
  Share
  Report
- SarohiwalSarohiwal
  ·11-29
  $AMD 20260717 150.0 PUT$
  38 Comment
  1
  Share
  Report
- SarohiwalSarohiwal
  ·11-29
  $APLD 20260717 14.0 PUT$
  148 Comment
  Like
  Share
  Report
No following yet

Most Discussed

{"i18n":{"language":"en_US"},"isCurrentUser":false,"userPageInfo":{"id":"4217035253675822","uuid":"4217035253675822","gmtCreate":1753932058460,"gmtModify":1759376176713,"name":"Sarohiwal","pinyin":"sarohiwal","introduction":"","introductionEn":null,"signature":"Entry level person in stocks & options in 2025","avatar":"https://community-static.tradeup.com/news/2e1ca78599ce252ed2578f03b69bad93","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":13,"headSize":24,"tweetSize":100,"questionSize":0,"limitLevel":999,"accountStatus":1,"level":{"id":0,"name":"","nameTw":"","represent":"","factor":"","iconColor":"","bgColor":""},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":"init","userBadges":[{"badgeId":"44212b71d0be4ec88898348dbe882e03-2","templateUuid":"44212b71d0be4ec88898348dbe882e03","name":"Executive Tiger","description":"The transaction amount of the securities account reaches $300,000","bigImgUrl":"https://static.tigerbbs.com/9d20b23f1b6335407f882bc5c2ad12c0","smallImgUrl":"https://static.tigerbbs.com/ada3b4533518ace8404a3f6dd192bd29","grayImgUrl":"https://static.tigerbbs.com/177f283ba21d1c077054dac07f88f3bd","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":1,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2025.11.27","exceedPercentage":"80.83%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101},{"badgeId":"972123088c9646f7b6091ae0662215be-3","templateUuid":"972123088c9646f7b6091ae0662215be","name":"Legendary Trader","description":"Total number of securities or futures transactions reached 300","bigImgUrl":"https://static.tigerbbs.com/656db16598a0b8f21429e10d6c1cb033","smallImgUrl":"https://static.tigerbbs.com/03f10910d4dd9234f9b5702a3342193a","grayImgUrl":"https://static.tigerbbs.com/0c767e35268feb729d50d3fa9a386c5a","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2025.10.30","exceedPercentage":"93.60%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"a83d7582f45846ffbccbce770ce65d84-1","templateUuid":"a83d7582f45846ffbccbce770ce65d84","name":"Real Trader","description":"Completed a transaction","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2025.08.07","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":3,"currentWearingBadge":{"badgeId":"44212b71d0be4ec88898348dbe882e03-2","templateUuid":"44212b71d0be4ec88898348dbe882e03","name":"Executive Tiger","description":"The transaction amount of the securities account reaches $300,000","bigImgUrl":"https://static.tigerbbs.com/9d20b23f1b6335407f882bc5c2ad12c0","smallImgUrl":"https://static.tigerbbs.com/ada3b4533518ace8404a3f6dd192bd29","grayImgUrl":"https://static.tigerbbs.com/177f283ba21d1c077054dac07f88f3bd","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":1,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2025.11.27","exceedPercentage":"80.98%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101},"individualDisplayBadges":null,"crmLevel":12,"crmLevelSwitch":1,"location":null,"starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":12,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"page":1,"watchlist":null,"tweetList":[{"id":506789415989840,"gmtCreate":1764749593350,"gmtModify":1764749594812,"author":{"id":"4217035253675822","authorId":"4217035253675822","name":"Sarohiwal","avatar":"https://community-static.tradeup.com/news/2e1ca78599ce252ed2578f03b69bad93","crmLevel":12,"crmLevelSwitch":1,"followedFlag":false,"authorIdStr":"4217035253675822","idStr":"4217035253675822"},"themes":[],"title":"","htmlText":"<a href=\"https://ttm.financial/OPT/SOXS 20260220 3.0 PUT\">$SOXS 20260220 3.0 PUT$</a>&nbsp;","listText":"<a href=\"https://ttm.financial/OPT/SOXS 20260220 3.0 PUT\">$SOXS 20260220 3.0 PUT$</a>&nbsp;","text":"$SOXS 20260220 3.0 PUT$","images":[{"img":"https://community-static.tradeup.com/news/f8d9fb85f0ca3d653062cbc35da7cf19","width":"618","height":"1066"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/506789415989840","isVote":1,"tweetType":1,"viewCount":14,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":506789020209392,"gmtCreate":1764749584346,"gmtModify":1764749586191,"author":{"id":"4217035253675822","authorId":"4217035253675822","name":"Sarohiwal","avatar":"https://community-static.tradeup.com/news/2e1ca78599ce252ed2578f03b69bad93","crmLevel":12,"crmLevelSwitch":1,"followedFlag":false,"authorIdStr":"4217035253675822","idStr":"4217035253675822"},"themes":[],"title":"","htmlText":"<a href=\"https://ttm.financial/OPT/SOXS 20260220 3.0 PUT\">$SOXS 20260220 3.0 PUT$</a>&nbsp;","listText":"<a href=\"https://ttm.financial/OPT/SOXS 20260220 3.0 PUT\">$SOXS 20260220 3.0 PUT$</a>&nbsp;","text":"$SOXS 20260220 3.0 PUT$","images":[{"img":"https://community-static.tradeup.com/news/f8d9fb85f0ca3d653062cbc35da7cf19","width":"618","height":"1066"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/506789020209392","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":506789412856104,"gmtCreate":1764749575925,"gmtModify":1764749578436,"author":{"id":"4217035253675822","authorId":"4217035253675822","name":"Sarohiwal","avatar":"https://community-static.tradeup.com/news/2e1ca78599ce252ed2578f03b69bad93","crmLevel":12,"crmLevelSwitch":1,"followedFlag":false,"authorIdStr":"4217035253675822","idStr":"4217035253675822"},"themes":[],"title":"","htmlText":"<a href=\"https://ttm.financial/OPT/SOXS 20260220 3.0 PUT\">$SOXS 20260220 3.0 PUT$</a>&nbsp;","listText":"<a href=\"https://ttm.financial/OPT/SOXS 20260220 3.0 PUT\">$SOXS 20260220 3.0 PUT$</a>&nbsp;","text":"$SOXS 20260220 3.0 PUT$","images":[{"img":"https://community-static.tradeup.com/news/a4223673ae7f28ed87266432287eba43","width":"618","height":"1066"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/506789412856104","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":506429763883648,"gmtCreate":1764659413268,"gmtModify":1764659416127,"author":{"id":"4217035253675822","authorId":"4217035253675822","name":"Sarohiwal","avatar":"https://community-static.tradeup.com/news/2e1ca78599ce252ed2578f03b69bad93","crmLevel":12,"crmLevelSwitch":1,"followedFlag":false,"authorIdStr":"4217035253675822","idStr":"4217035253675822"},"themes":[],"title":"","htmlText":"<a href=\"https://ttm.financial/OPT/MU 20260618 135.0 PUT\">$MU 20260618 135.0 PUT$</a>&nbsp;","listText":"<a href=\"https://ttm.financial/OPT/MU 20260618 135.0 PUT\">$MU 20260618 135.0 PUT$</a>&nbsp;","text":"$MU 20260618 135.0 PUT$","images":[{"img":"https://community-static.tradeup.com/news/13b4ff87ae9cdd892aeb868efbc7688a","width":"618","height":"1066"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/506429763883648","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":506044891820904,"gmtCreate":1764554378508,"gmtModify":1764554382107,"author":{"id":"4217035253675822","authorId":"4217035253675822","name":"Sarohiwal","avatar":"https://community-static.tradeup.com/news/2e1ca78599ce252ed2578f03b69bad93","crmLevel":12,"crmLevelSwitch":1,"followedFlag":false,"authorIdStr":"4217035253675822","idStr":"4217035253675822"},"themes":[],"title":"","htmlText":"Share your opinion about this news…","listText":"Share your opinion about this news…","text":"Share your opinion about this news…","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/506044891820904","repostId":"2588790413","repostType":2,"repost":{"id":"2588790413","kind":"highlight","weMediaInfo":{"introduction":"Share your news with media, investors, and consumers with targeted distribution options from one of the world’s largest and most trusted newswires.","home_visible":1,"media_name":"GlobeNewswire","id":"1016364462","head_image":"https://static.tigerbbs.com/31bb960c88eab45f27ccc9fce75dee9a"},"pubTimestamp":1764522000,"share":"https://ttm.financial/m/news/2588790413?lang=&edition=fundamental","pubTime":"2025-12-01 01:00","market":"us","language":"en","title":"Philips launches Verida, world’s first detector-based spectral CT powered by breakthrough AI, to advance diagnostic precision","url":"https://stock-news.laohu8.com/highlight/detail?id=2588790413","media":"GlobeNewswire","summary":"Philips Verida spectral CT system, straight-on view. Philips Verida spectral CT system, straight-on view","content":"<html><body><div>\n<p>Philips Verida spectral CT system, angle view</p>\n<figure>\n<img src=\"https://ml-eu.globenewswire.com/Resource/Download/0f59434e-9a2a-4543-a32d-f11ae5abf3f3\" title=\"Philips Verida spectral CT system, angle view\"/>\n<figcaption>Philips Verida spectral CT system, angle view</figcaption>\n</figure>\n</div><div>\n<p>Philips Verida spectral CT system, straight-on view</p>\n<figure>\n<img src=\"https://ml-eu.globenewswire.com/Resource/Download/0441428b-ccdb-4553-bed6-2f2926f74c62\" title=\"Philips Verida spectral CT system, straight-on view\"/>\n<figcaption>Philips Verida spectral CT system, straight-on view</figcaption>\n</figure>\n</div><p>November 30, 2025</p> <ul><li><i>Philips pioneered detector-based spectral CT, which has been widely adopted in clinical routine exams across anatomies, supported by over 800 peer-reviewed publications [1]</i></li><li><i>CE-marked, 510k pending Verida CT [2] integrates AI across the imaging chain, providing superb image quality while accelerating workflow and reducing dose [3, 4]</i></li></ul> <p><b>Amsterdam, the Netherlands and Chicago, USA</b> – At RSNA 2025, Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the launch of Verida, the world’s first detector-based spectral CT fully powered by AI. This marks a transformative milestone in CT, with AI optimizing the entire imaging chain – lowering system noise, elevating image quality, and accelerating clinical workflow.</p> <p>With over 800 global installations and supported by over 800 peer-reviewed publications, Philips’ spectral CT uses PACS-native delivery and has been fully embedded into clinical workflow. Spectral CT measures how tissues absorb different x-ray energy levels, enabling differentiation of materials that appear identical on conventional CT. Philips has pioneered detector-based spectral CT, delivering multiple spectral results from a single scan with no tradeoffs in performance or scan time.</p> <p>Now, by integrating AI across the imaging chain, from acquisition to reconstruction, Philips Verida generates industry-leading, superior spectral image quality with minimal noise, in addition to high-definition conventional images. With its full AI capabilities, Verida can achieve dramatic dose reduction [5] without compromising image quality and reduce energy consumption by up to 45% [6].</p> <p>“The clinical benefits of Verida will fundamentally change my approach to cardiac imaging,” said Prof. Eliseo Vañó Galván, cardiovascular radiologist, Chairman of the CT &amp; MR Department at Hospital Nuestra. Sra. Del Rosario, Madrid, Spain. “With more comprehensive insights in every cardiac CT, I plan to make spectral imaging routine for all patients – building toward a fully spectral CT department. We evaluated many systems, including photon-counting CT, but chose Philips because it delivers the precision we need in a streamlined, easy-to-use platform. The result is greater diagnostic confidence and the potential to reduce the need for invasive angiograms – not just in cardiology, but across other clinical areas as well [7].”</p> <p>Verida reconstructs 145 images per second, so entire exams automatically appear in less than 30 seconds – 2× faster than before and enabling up to 270 exams every day [8]. Building on Philips’ proprietary Spectral Precise Image technology – a deep learning AI reconstruction engine combined with advanced spectral imaging – and its third-generation Nano-panel Precise dual-layer detector with intrinsic noise reduction optimized for AI, Verida is designed to deliver faster, more dose-efficient spectral reconstructions. This enables clinicians to access rich spectral information from a single scan.</p> <p>“Combining the latest advances in our proven spectral CT technology with AI, our flagship Verida CT system is designed to set a new standard in superior image quality and accelerated scans which are fully embedded in the radiology workflow, all to help clinicians detect and characterize disease earlier, reduce variability in diagnoses, and support efficient treatment pathways – in a single scan,” said Dan Xu, Business Leader of CT at Philips. “While photon-counting CT adds complexity, is yet to move from the research arena into clinical practice, Philips spectral CT has been a clinical workhorse for more than a decade and delivers comparable or better clinical outcomes, standing up to the most demanding throughput and at significantly lower total cost of ownership”.</p> <p>Verida extends Philips’ software-defined CT approach, pairing AI-driven spectral precision to advance both clinical and operational outcomes. Built for high-demand environments, it streamlines workflows, reduces repeat scans, and delivers consistently sharp imaging across all care pathways.</p> <p>Philips is debuting Verida at RSNA 2025, with availability in select markets beginning in 2026 [9].</p> <p>[1] Data on file.  <br/>[2] CE marked and 510(k) pending. Not currently available for sale in the US.<br/>[3] Andersen MB et al. Impact of spectral body imaging in patients suspected for occult cancer: a prospective study of 503 patients. Eur Radiol2020. doi.org/10.1007/s00330-020-06878-7<br/>[4] Andersen MB et al. Economic impact of spectral body imaging in the diagnosis of patients suspected of occult cancer. Insights into Imaging 2021. doi.org/10.1186/s13244-021-01116-0. Results of customer testimonies are not predictive of results in other cases, where results may vary.<br/>[5] Dose reduction assessments were performed using reference body protocol. In clinical practice, the use of Spectral Precise Image may reduce CT patient dose depending on the clinical task, patient size, and anatomical location. A consultation with a radiologist and a physicist should be made to determine the appropriate dose to obtain diagnostic image quality for the particular clinical task. <br/>[6] Based on Axial Body 3D Scan with 80% dose reduction. Energy savings for system preparation is not included.<br/>[7] Spectral CT Verida Premium up to 270 (4 CIRS config) exams a day (16 hours dual shift working day) meeting the needs of radiology departments with extended work hours and very high patient throughput.<br/>[8] The statements of the clinician reflect independent opinion and are not intended to imply product performance prior to regulatory clearance.<br/>[9] Pending regulatory clearance.</p> <p><b>For further information, please contact:</b></p> <p>Anna Hogrebe<br/>Philips Global External Relations<br/>Tel.: +1 416 270 6757<br/>E-mail: anna.hogrebe@philips.com</p> <p><b><b>About Royal Philips</b></b></p> <p>Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people’s health and well-being through meaningful innovation. Philips’ patient- and people-centric innovation leverages advanced technology and deep clinical and consumer insights to deliver personal health solutions for consumers and professional health solutions for healthcare providers and their patients in the hospital and the home.<br/><br/>Headquartered in the Netherlands, the company is a leader in diagnostic imaging, ultrasound, image-guided therapy, monitoring and enterprise informatics, as well as in personal health. Philips generated 2024 sales of EUR 18 billion and employs approximately 67,000 employees with sales and services in more than 100 countries. News about Philips can be found at www.philips.com/newscenter.</p> <p>\n<strong>Attachments</strong>\n</p>\n<ul>\n<li>\nPhilips Verida spectral CT system, angle view\n</li>\n<li>\nPhilips Verida spectral CT system, straight-on view\n</li>\n</ul>\n<br/><img referrerpolicy=\"no-referrer-when-downgrade\" src=\"https://ml-eu.globenewswire.com/media/ODdiNDMyNTUtZGFmMy00MWZlLTgyOTctYzgwOWRkNDY5ZWMzLTEwMTQzNzUtMjAyNS0xMS0zMC1lbg==/tiny/Philips-International-B-V-.png\"/></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Philips launches Verida, world’s first detector-based spectral CT powered by breakthrough AI, to advance diagnostic precision</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPhilips launches Verida, world’s first detector-based spectral CT powered by breakthrough AI, to advance diagnostic precision\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1016364462\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/31bb960c88eab45f27ccc9fce75dee9a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">GlobeNewswire </p>\n<p class=\"h-time\">2025-12-01 01:00</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><div>\n<p>Philips Verida spectral CT system, angle view</p>\n<figure>\n<img src=\"https://ml-eu.globenewswire.com/Resource/Download/0f59434e-9a2a-4543-a32d-f11ae5abf3f3\" title=\"Philips Verida spectral CT system, angle view\"/>\n<figcaption>Philips Verida spectral CT system, angle view</figcaption>\n</figure>\n</div><div>\n<p>Philips Verida spectral CT system, straight-on view</p>\n<figure>\n<img src=\"https://ml-eu.globenewswire.com/Resource/Download/0441428b-ccdb-4553-bed6-2f2926f74c62\" title=\"Philips Verida spectral CT system, straight-on view\"/>\n<figcaption>Philips Verida spectral CT system, straight-on view</figcaption>\n</figure>\n</div><p>November 30, 2025</p> <ul><li><i>Philips pioneered detector-based spectral CT, which has been widely adopted in clinical routine exams across anatomies, supported by over 800 peer-reviewed publications [1]</i></li><li><i>CE-marked, 510k pending Verida CT [2] integrates AI across the imaging chain, providing superb image quality while accelerating workflow and reducing dose [3, 4]</i></li></ul> <p><b>Amsterdam, the Netherlands and Chicago, USA</b> – At RSNA 2025, Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the launch of Verida, the world’s first detector-based spectral CT fully powered by AI. This marks a transformative milestone in CT, with AI optimizing the entire imaging chain – lowering system noise, elevating image quality, and accelerating clinical workflow.</p> <p>With over 800 global installations and supported by over 800 peer-reviewed publications, Philips’ spectral CT uses PACS-native delivery and has been fully embedded into clinical workflow. Spectral CT measures how tissues absorb different x-ray energy levels, enabling differentiation of materials that appear identical on conventional CT. Philips has pioneered detector-based spectral CT, delivering multiple spectral results from a single scan with no tradeoffs in performance or scan time.</p> <p>Now, by integrating AI across the imaging chain, from acquisition to reconstruction, Philips Verida generates industry-leading, superior spectral image quality with minimal noise, in addition to high-definition conventional images. With its full AI capabilities, Verida can achieve dramatic dose reduction [5] without compromising image quality and reduce energy consumption by up to 45% [6].</p> <p>“The clinical benefits of Verida will fundamentally change my approach to cardiac imaging,” said Prof. Eliseo Vañó Galván, cardiovascular radiologist, Chairman of the CT &amp; MR Department at Hospital Nuestra. Sra. Del Rosario, Madrid, Spain. “With more comprehensive insights in every cardiac CT, I plan to make spectral imaging routine for all patients – building toward a fully spectral CT department. We evaluated many systems, including photon-counting CT, but chose Philips because it delivers the precision we need in a streamlined, easy-to-use platform. The result is greater diagnostic confidence and the potential to reduce the need for invasive angiograms – not just in cardiology, but across other clinical areas as well [7].”</p> <p>Verida reconstructs 145 images per second, so entire exams automatically appear in less than 30 seconds – 2× faster than before and enabling up to 270 exams every day [8]. Building on Philips’ proprietary Spectral Precise Image technology – a deep learning AI reconstruction engine combined with advanced spectral imaging – and its third-generation Nano-panel Precise dual-layer detector with intrinsic noise reduction optimized for AI, Verida is designed to deliver faster, more dose-efficient spectral reconstructions. This enables clinicians to access rich spectral information from a single scan.</p> <p>“Combining the latest advances in our proven spectral CT technology with AI, our flagship Verida CT system is designed to set a new standard in superior image quality and accelerated scans which are fully embedded in the radiology workflow, all to help clinicians detect and characterize disease earlier, reduce variability in diagnoses, and support efficient treatment pathways – in a single scan,” said Dan Xu, Business Leader of CT at Philips. “While photon-counting CT adds complexity, is yet to move from the research arena into clinical practice, Philips spectral CT has been a clinical workhorse for more than a decade and delivers comparable or better clinical outcomes, standing up to the most demanding throughput and at significantly lower total cost of ownership”.</p> <p>Verida extends Philips’ software-defined CT approach, pairing AI-driven spectral precision to advance both clinical and operational outcomes. Built for high-demand environments, it streamlines workflows, reduces repeat scans, and delivers consistently sharp imaging across all care pathways.</p> <p>Philips is debuting Verida at RSNA 2025, with availability in select markets beginning in 2026 [9].</p> <p>[1] Data on file.  <br/>[2] CE marked and 510(k) pending. Not currently available for sale in the US.<br/>[3] Andersen MB et al. Impact of spectral body imaging in patients suspected for occult cancer: a prospective study of 503 patients. Eur Radiol2020. doi.org/10.1007/s00330-020-06878-7<br/>[4] Andersen MB et al. Economic impact of spectral body imaging in the diagnosis of patients suspected of occult cancer. Insights into Imaging 2021. doi.org/10.1186/s13244-021-01116-0. Results of customer testimonies are not predictive of results in other cases, where results may vary.<br/>[5] Dose reduction assessments were performed using reference body protocol. In clinical practice, the use of Spectral Precise Image may reduce CT patient dose depending on the clinical task, patient size, and anatomical location. A consultation with a radiologist and a physicist should be made to determine the appropriate dose to obtain diagnostic image quality for the particular clinical task. <br/>[6] Based on Axial Body 3D Scan with 80% dose reduction. Energy savings for system preparation is not included.<br/>[7] Spectral CT Verida Premium up to 270 (4 CIRS config) exams a day (16 hours dual shift working day) meeting the needs of radiology departments with extended work hours and very high patient throughput.<br/>[8] The statements of the clinician reflect independent opinion and are not intended to imply product performance prior to regulatory clearance.<br/>[9] Pending regulatory clearance.</p> <p><b>For further information, please contact:</b></p> <p>Anna Hogrebe<br/>Philips Global External Relations<br/>Tel.: +1 416 270 6757<br/>E-mail: anna.hogrebe@philips.com</p> <p><b><b>About Royal Philips</b></b></p> <p>Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people’s health and well-being through meaningful innovation. Philips’ patient- and people-centric innovation leverages advanced technology and deep clinical and consumer insights to deliver personal health solutions for consumers and professional health solutions for healthcare providers and their patients in the hospital and the home.<br/><br/>Headquartered in the Netherlands, the company is a leader in diagnostic imaging, ultrasound, image-guided therapy, monitoring and enterprise informatics, as well as in personal health. Philips generated 2024 sales of EUR 18 billion and employs approximately 67,000 employees with sales and services in more than 100 countries. News about Philips can be found at www.philips.com/newscenter.</p> <p>\n<strong>Attachments</strong>\n</p>\n<ul>\n<li>\nPhilips Verida spectral CT system, angle view\n</li>\n<li>\nPhilips Verida spectral CT system, straight-on view\n</li>\n</ul>\n<br/><img referrerpolicy=\"no-referrer-when-downgrade\" src=\"https://ml-eu.globenewswire.com/media/ODdiNDMyNTUtZGFmMy00MWZlLTgyOTctYzgwOWRkNDY5ZWMzLTEwMTQzNzUtMjAyNS0xMS0zMC1lbg==/tiny/Philips-International-B-V-.png\"/></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4543":"AI","BK4551":"寇图资本持仓","BK4587":"ChatGPT概念","BK4082":"医疗保健设备","BK4528":"SaaS概念","BK4588":"碎股","BK4585":"ETF&股票定投概念","PHG":"飞利浦","BK4023":"应用软件","AI":"C3.ai, Inc."},"source_url":"https://www.globenewswire.com/news-release/2025/11/30/3196599/0/en/Philips-launches-Verida-world-s-first-detector-based-spectral-CT-powered-by-breakthrough-AI-to-advance-diagnostic-precision.html","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2588790413","content_text":"Philips Verida spectral CT system, angle view\n\n\nPhilips Verida spectral CT system, angle view\n\n\nPhilips Verida spectral CT system, straight-on view\n\n\nPhilips Verida spectral CT system, straight-on view\n\nNovember 30, 2025 Philips pioneered detector-based spectral CT, which has been widely adopted in clinical routine exams across anatomies, supported by over 800 peer-reviewed publications [1]CE-marked, 510k pending Verida CT [2] integrates AI across the imaging chain, providing superb image quality while accelerating workflow and reducing dose [3, 4] Amsterdam, the Netherlands and Chicago, USA – At RSNA 2025, Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the launch of Verida, the world’s first detector-based spectral CT fully powered by AI. This marks a transformative milestone in CT, with AI optimizing the entire imaging chain – lowering system noise, elevating image quality, and accelerating clinical workflow. With over 800 global installations and supported by over 800 peer-reviewed publications, Philips’ spectral CT uses PACS-native delivery and has been fully embedded into clinical workflow. Spectral CT measures how tissues absorb different x-ray energy levels, enabling differentiation of materials that appear identical on conventional CT. Philips has pioneered detector-based spectral CT, delivering multiple spectral results from a single scan with no tradeoffs in performance or scan time. Now, by integrating AI across the imaging chain, from acquisition to reconstruction, Philips Verida generates industry-leading, superior spectral image quality with minimal noise, in addition to high-definition conventional images. With its full AI capabilities, Verida can achieve dramatic dose reduction [5] without compromising image quality and reduce energy consumption by up to 45% [6]. “The clinical benefits of Verida will fundamentally change my approach to cardiac imaging,” said Prof. Eliseo Vañó Galván, cardiovascular radiologist, Chairman of the CT & MR Department at Hospital Nuestra. Sra. Del Rosario, Madrid, Spain. “With more comprehensive insights in every cardiac CT, I plan to make spectral imaging routine for all patients – building toward a fully spectral CT department. We evaluated many systems, including photon-counting CT, but chose Philips because it delivers the precision we need in a streamlined, easy-to-use platform. The result is greater diagnostic confidence and the potential to reduce the need for invasive angiograms – not just in cardiology, but across other clinical areas as well [7].” Verida reconstructs 145 images per second, so entire exams automatically appear in less than 30 seconds – 2× faster than before and enabling up to 270 exams every day [8]. Building on Philips’ proprietary Spectral Precise Image technology – a deep learning AI reconstruction engine combined with advanced spectral imaging – and its third-generation Nano-panel Precise dual-layer detector with intrinsic noise reduction optimized for AI, Verida is designed to deliver faster, more dose-efficient spectral reconstructions. This enables clinicians to access rich spectral information from a single scan. “Combining the latest advances in our proven spectral CT technology with AI, our flagship Verida CT system is designed to set a new standard in superior image quality and accelerated scans which are fully embedded in the radiology workflow, all to help clinicians detect and characterize disease earlier, reduce variability in diagnoses, and support efficient treatment pathways – in a single scan,” said Dan Xu, Business Leader of CT at Philips. “While photon-counting CT adds complexity, is yet to move from the research arena into clinical practice, Philips spectral CT has been a clinical workhorse for more than a decade and delivers comparable or better clinical outcomes, standing up to the most demanding throughput and at significantly lower total cost of ownership”. Verida extends Philips’ software-defined CT approach, pairing AI-driven spectral precision to advance both clinical and operational outcomes. Built for high-demand environments, it streamlines workflows, reduces repeat scans, and delivers consistently sharp imaging across all care pathways. Philips is debuting Verida at RSNA 2025, with availability in select markets beginning in 2026 [9]. [1] Data on file.  [2] CE marked and 510(k) pending. Not currently available for sale in the US.[3] Andersen MB et al. Impact of spectral body imaging in patients suspected for occult cancer: a prospective study of 503 patients. Eur Radiol2020. doi.org/10.1007/s00330-020-06878-7[4] Andersen MB et al. Economic impact of spectral body imaging in the diagnosis of patients suspected of occult cancer. Insights into Imaging 2021. doi.org/10.1186/s13244-021-01116-0. Results of customer testimonies are not predictive of results in other cases, where results may vary.[5] Dose reduction assessments were performed using reference body protocol. In clinical practice, the use of Spectral Precise Image may reduce CT patient dose depending on the clinical task, patient size, and anatomical location. A consultation with a radiologist and a physicist should be made to determine the appropriate dose to obtain diagnostic image quality for the particular clinical task. [6] Based on Axial Body 3D Scan with 80% dose reduction. Energy savings for system preparation is not included.[7] Spectral CT Verida Premium up to 270 (4 CIRS config) exams a day (16 hours dual shift working day) meeting the needs of radiology departments with extended work hours and very high patient throughput.[8] The statements of the clinician reflect independent opinion and are not intended to imply product performance prior to regulatory clearance.[9] Pending regulatory clearance. For further information, please contact: Anna HogrebePhilips Global External RelationsTel.: +1 416 270 6757E-mail: anna.hogrebe@philips.com About Royal Philips Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people’s health and well-being through meaningful innovation. Philips’ patient- and people-centric innovation leverages advanced technology and deep clinical and consumer insights to deliver personal health solutions for consumers and professional health solutions for healthcare providers and their patients in the hospital and the home.Headquartered in the Netherlands, the company is a leader in diagnostic imaging, ultrasound, image-guided therapy, monitoring and enterprise informatics, as well as in personal health. Philips generated 2024 sales of EUR 18 billion and employs approximately 67,000 employees with sales and services in more than 100 countries. News about Philips can be found at www.philips.com/newscenter. \nAttachments\n\n\n\nPhilips Verida spectral CT system, angle view\n\n\nPhilips Verida spectral CT system, straight-on view","news_type":1,"symbols_score_info":{"AI":0.86,"PHG":1}},"isVote":1,"tweetType":1,"viewCount":1,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":506045326914192,"gmtCreate":1764554367516,"gmtModify":1764554371194,"author":{"id":"4217035253675822","authorId":"4217035253675822","name":"Sarohiwal","avatar":"https://community-static.tradeup.com/news/2e1ca78599ce252ed2578f03b69bad93","crmLevel":12,"crmLevelSwitch":1,"followedFlag":false,"authorIdStr":"4217035253675822","idStr":"4217035253675822"},"themes":[],"title":"","htmlText":"Excellent product, will Help lots of patients across the world for accurate diagnostics.","listText":"Excellent product, will Help lots of patients across the world for accurate diagnostics.","text":"Excellent product, will Help lots of patients across the world for accurate diagnostics.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/506045326914192","repostId":"2588790413","repostType":2,"repost":{"id":"2588790413","kind":"highlight","weMediaInfo":{"introduction":"Share your news with media, investors, and consumers with targeted distribution options from one of the world’s largest and most trusted newswires.","home_visible":1,"media_name":"GlobeNewswire","id":"1016364462","head_image":"https://static.tigerbbs.com/31bb960c88eab45f27ccc9fce75dee9a"},"pubTimestamp":1764522000,"share":"https://ttm.financial/m/news/2588790413?lang=&edition=fundamental","pubTime":"2025-12-01 01:00","market":"us","language":"en","title":"Philips launches Verida, world’s first detector-based spectral CT powered by breakthrough AI, to advance diagnostic precision","url":"https://stock-news.laohu8.com/highlight/detail?id=2588790413","media":"GlobeNewswire","summary":"Philips Verida spectral CT system, straight-on view. Philips Verida spectral CT system, straight-on view","content":"<html><body><div>\n<p>Philips Verida spectral CT system, angle view</p>\n<figure>\n<img src=\"https://ml-eu.globenewswire.com/Resource/Download/0f59434e-9a2a-4543-a32d-f11ae5abf3f3\" title=\"Philips Verida spectral CT system, angle view\"/>\n<figcaption>Philips Verida spectral CT system, angle view</figcaption>\n</figure>\n</div><div>\n<p>Philips Verida spectral CT system, straight-on view</p>\n<figure>\n<img src=\"https://ml-eu.globenewswire.com/Resource/Download/0441428b-ccdb-4553-bed6-2f2926f74c62\" title=\"Philips Verida spectral CT system, straight-on view\"/>\n<figcaption>Philips Verida spectral CT system, straight-on view</figcaption>\n</figure>\n</div><p>November 30, 2025</p> <ul><li><i>Philips pioneered detector-based spectral CT, which has been widely adopted in clinical routine exams across anatomies, supported by over 800 peer-reviewed publications [1]</i></li><li><i>CE-marked, 510k pending Verida CT [2] integrates AI across the imaging chain, providing superb image quality while accelerating workflow and reducing dose [3, 4]</i></li></ul> <p><b>Amsterdam, the Netherlands and Chicago, USA</b> – At RSNA 2025, Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the launch of Verida, the world’s first detector-based spectral CT fully powered by AI. This marks a transformative milestone in CT, with AI optimizing the entire imaging chain – lowering system noise, elevating image quality, and accelerating clinical workflow.</p> <p>With over 800 global installations and supported by over 800 peer-reviewed publications, Philips’ spectral CT uses PACS-native delivery and has been fully embedded into clinical workflow. Spectral CT measures how tissues absorb different x-ray energy levels, enabling differentiation of materials that appear identical on conventional CT. Philips has pioneered detector-based spectral CT, delivering multiple spectral results from a single scan with no tradeoffs in performance or scan time.</p> <p>Now, by integrating AI across the imaging chain, from acquisition to reconstruction, Philips Verida generates industry-leading, superior spectral image quality with minimal noise, in addition to high-definition conventional images. With its full AI capabilities, Verida can achieve dramatic dose reduction [5] without compromising image quality and reduce energy consumption by up to 45% [6].</p> <p>“The clinical benefits of Verida will fundamentally change my approach to cardiac imaging,” said Prof. Eliseo Vañó Galván, cardiovascular radiologist, Chairman of the CT &amp; MR Department at Hospital Nuestra. Sra. Del Rosario, Madrid, Spain. “With more comprehensive insights in every cardiac CT, I plan to make spectral imaging routine for all patients – building toward a fully spectral CT department. We evaluated many systems, including photon-counting CT, but chose Philips because it delivers the precision we need in a streamlined, easy-to-use platform. The result is greater diagnostic confidence and the potential to reduce the need for invasive angiograms – not just in cardiology, but across other clinical areas as well [7].”</p> <p>Verida reconstructs 145 images per second, so entire exams automatically appear in less than 30 seconds – 2× faster than before and enabling up to 270 exams every day [8]. Building on Philips’ proprietary Spectral Precise Image technology – a deep learning AI reconstruction engine combined with advanced spectral imaging – and its third-generation Nano-panel Precise dual-layer detector with intrinsic noise reduction optimized for AI, Verida is designed to deliver faster, more dose-efficient spectral reconstructions. This enables clinicians to access rich spectral information from a single scan.</p> <p>“Combining the latest advances in our proven spectral CT technology with AI, our flagship Verida CT system is designed to set a new standard in superior image quality and accelerated scans which are fully embedded in the radiology workflow, all to help clinicians detect and characterize disease earlier, reduce variability in diagnoses, and support efficient treatment pathways – in a single scan,” said Dan Xu, Business Leader of CT at Philips. “While photon-counting CT adds complexity, is yet to move from the research arena into clinical practice, Philips spectral CT has been a clinical workhorse for more than a decade and delivers comparable or better clinical outcomes, standing up to the most demanding throughput and at significantly lower total cost of ownership”.</p> <p>Verida extends Philips’ software-defined CT approach, pairing AI-driven spectral precision to advance both clinical and operational outcomes. Built for high-demand environments, it streamlines workflows, reduces repeat scans, and delivers consistently sharp imaging across all care pathways.</p> <p>Philips is debuting Verida at RSNA 2025, with availability in select markets beginning in 2026 [9].</p> <p>[1] Data on file.  <br/>[2] CE marked and 510(k) pending. Not currently available for sale in the US.<br/>[3] Andersen MB et al. Impact of spectral body imaging in patients suspected for occult cancer: a prospective study of 503 patients. Eur Radiol2020. doi.org/10.1007/s00330-020-06878-7<br/>[4] Andersen MB et al. Economic impact of spectral body imaging in the diagnosis of patients suspected of occult cancer. Insights into Imaging 2021. doi.org/10.1186/s13244-021-01116-0. Results of customer testimonies are not predictive of results in other cases, where results may vary.<br/>[5] Dose reduction assessments were performed using reference body protocol. In clinical practice, the use of Spectral Precise Image may reduce CT patient dose depending on the clinical task, patient size, and anatomical location. A consultation with a radiologist and a physicist should be made to determine the appropriate dose to obtain diagnostic image quality for the particular clinical task. <br/>[6] Based on Axial Body 3D Scan with 80% dose reduction. Energy savings for system preparation is not included.<br/>[7] Spectral CT Verida Premium up to 270 (4 CIRS config) exams a day (16 hours dual shift working day) meeting the needs of radiology departments with extended work hours and very high patient throughput.<br/>[8] The statements of the clinician reflect independent opinion and are not intended to imply product performance prior to regulatory clearance.<br/>[9] Pending regulatory clearance.</p> <p><b>For further information, please contact:</b></p> <p>Anna Hogrebe<br/>Philips Global External Relations<br/>Tel.: +1 416 270 6757<br/>E-mail: anna.hogrebe@philips.com</p> <p><b><b>About Royal Philips</b></b></p> <p>Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people’s health and well-being through meaningful innovation. Philips’ patient- and people-centric innovation leverages advanced technology and deep clinical and consumer insights to deliver personal health solutions for consumers and professional health solutions for healthcare providers and their patients in the hospital and the home.<br/><br/>Headquartered in the Netherlands, the company is a leader in diagnostic imaging, ultrasound, image-guided therapy, monitoring and enterprise informatics, as well as in personal health. Philips generated 2024 sales of EUR 18 billion and employs approximately 67,000 employees with sales and services in more than 100 countries. News about Philips can be found at www.philips.com/newscenter.</p> <p>\n<strong>Attachments</strong>\n</p>\n<ul>\n<li>\nPhilips Verida spectral CT system, angle view\n</li>\n<li>\nPhilips Verida spectral CT system, straight-on view\n</li>\n</ul>\n<br/><img referrerpolicy=\"no-referrer-when-downgrade\" src=\"https://ml-eu.globenewswire.com/media/ODdiNDMyNTUtZGFmMy00MWZlLTgyOTctYzgwOWRkNDY5ZWMzLTEwMTQzNzUtMjAyNS0xMS0zMC1lbg==/tiny/Philips-International-B-V-.png\"/></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Philips launches Verida, world’s first detector-based spectral CT powered by breakthrough AI, to advance diagnostic precision</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPhilips launches Verida, world’s first detector-based spectral CT powered by breakthrough AI, to advance diagnostic precision\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1016364462\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/31bb960c88eab45f27ccc9fce75dee9a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">GlobeNewswire </p>\n<p class=\"h-time\">2025-12-01 01:00</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><div>\n<p>Philips Verida spectral CT system, angle view</p>\n<figure>\n<img src=\"https://ml-eu.globenewswire.com/Resource/Download/0f59434e-9a2a-4543-a32d-f11ae5abf3f3\" title=\"Philips Verida spectral CT system, angle view\"/>\n<figcaption>Philips Verida spectral CT system, angle view</figcaption>\n</figure>\n</div><div>\n<p>Philips Verida spectral CT system, straight-on view</p>\n<figure>\n<img src=\"https://ml-eu.globenewswire.com/Resource/Download/0441428b-ccdb-4553-bed6-2f2926f74c62\" title=\"Philips Verida spectral CT system, straight-on view\"/>\n<figcaption>Philips Verida spectral CT system, straight-on view</figcaption>\n</figure>\n</div><p>November 30, 2025</p> <ul><li><i>Philips pioneered detector-based spectral CT, which has been widely adopted in clinical routine exams across anatomies, supported by over 800 peer-reviewed publications [1]</i></li><li><i>CE-marked, 510k pending Verida CT [2] integrates AI across the imaging chain, providing superb image quality while accelerating workflow and reducing dose [3, 4]</i></li></ul> <p><b>Amsterdam, the Netherlands and Chicago, USA</b> – At RSNA 2025, Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the launch of Verida, the world’s first detector-based spectral CT fully powered by AI. This marks a transformative milestone in CT, with AI optimizing the entire imaging chain – lowering system noise, elevating image quality, and accelerating clinical workflow.</p> <p>With over 800 global installations and supported by over 800 peer-reviewed publications, Philips’ spectral CT uses PACS-native delivery and has been fully embedded into clinical workflow. Spectral CT measures how tissues absorb different x-ray energy levels, enabling differentiation of materials that appear identical on conventional CT. Philips has pioneered detector-based spectral CT, delivering multiple spectral results from a single scan with no tradeoffs in performance or scan time.</p> <p>Now, by integrating AI across the imaging chain, from acquisition to reconstruction, Philips Verida generates industry-leading, superior spectral image quality with minimal noise, in addition to high-definition conventional images. With its full AI capabilities, Verida can achieve dramatic dose reduction [5] without compromising image quality and reduce energy consumption by up to 45% [6].</p> <p>“The clinical benefits of Verida will fundamentally change my approach to cardiac imaging,” said Prof. Eliseo Vañó Galván, cardiovascular radiologist, Chairman of the CT &amp; MR Department at Hospital Nuestra. Sra. Del Rosario, Madrid, Spain. “With more comprehensive insights in every cardiac CT, I plan to make spectral imaging routine for all patients – building toward a fully spectral CT department. We evaluated many systems, including photon-counting CT, but chose Philips because it delivers the precision we need in a streamlined, easy-to-use platform. The result is greater diagnostic confidence and the potential to reduce the need for invasive angiograms – not just in cardiology, but across other clinical areas as well [7].”</p> <p>Verida reconstructs 145 images per second, so entire exams automatically appear in less than 30 seconds – 2× faster than before and enabling up to 270 exams every day [8]. Building on Philips’ proprietary Spectral Precise Image technology – a deep learning AI reconstruction engine combined with advanced spectral imaging – and its third-generation Nano-panel Precise dual-layer detector with intrinsic noise reduction optimized for AI, Verida is designed to deliver faster, more dose-efficient spectral reconstructions. This enables clinicians to access rich spectral information from a single scan.</p> <p>“Combining the latest advances in our proven spectral CT technology with AI, our flagship Verida CT system is designed to set a new standard in superior image quality and accelerated scans which are fully embedded in the radiology workflow, all to help clinicians detect and characterize disease earlier, reduce variability in diagnoses, and support efficient treatment pathways – in a single scan,” said Dan Xu, Business Leader of CT at Philips. “While photon-counting CT adds complexity, is yet to move from the research arena into clinical practice, Philips spectral CT has been a clinical workhorse for more than a decade and delivers comparable or better clinical outcomes, standing up to the most demanding throughput and at significantly lower total cost of ownership”.</p> <p>Verida extends Philips’ software-defined CT approach, pairing AI-driven spectral precision to advance both clinical and operational outcomes. Built for high-demand environments, it streamlines workflows, reduces repeat scans, and delivers consistently sharp imaging across all care pathways.</p> <p>Philips is debuting Verida at RSNA 2025, with availability in select markets beginning in 2026 [9].</p> <p>[1] Data on file.  <br/>[2] CE marked and 510(k) pending. Not currently available for sale in the US.<br/>[3] Andersen MB et al. Impact of spectral body imaging in patients suspected for occult cancer: a prospective study of 503 patients. Eur Radiol2020. doi.org/10.1007/s00330-020-06878-7<br/>[4] Andersen MB et al. Economic impact of spectral body imaging in the diagnosis of patients suspected of occult cancer. Insights into Imaging 2021. doi.org/10.1186/s13244-021-01116-0. Results of customer testimonies are not predictive of results in other cases, where results may vary.<br/>[5] Dose reduction assessments were performed using reference body protocol. In clinical practice, the use of Spectral Precise Image may reduce CT patient dose depending on the clinical task, patient size, and anatomical location. A consultation with a radiologist and a physicist should be made to determine the appropriate dose to obtain diagnostic image quality for the particular clinical task. <br/>[6] Based on Axial Body 3D Scan with 80% dose reduction. Energy savings for system preparation is not included.<br/>[7] Spectral CT Verida Premium up to 270 (4 CIRS config) exams a day (16 hours dual shift working day) meeting the needs of radiology departments with extended work hours and very high patient throughput.<br/>[8] The statements of the clinician reflect independent opinion and are not intended to imply product performance prior to regulatory clearance.<br/>[9] Pending regulatory clearance.</p> <p><b>For further information, please contact:</b></p> <p>Anna Hogrebe<br/>Philips Global External Relations<br/>Tel.: +1 416 270 6757<br/>E-mail: anna.hogrebe@philips.com</p> <p><b><b>About Royal Philips</b></b></p> <p>Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people’s health and well-being through meaningful innovation. Philips’ patient- and people-centric innovation leverages advanced technology and deep clinical and consumer insights to deliver personal health solutions for consumers and professional health solutions for healthcare providers and their patients in the hospital and the home.<br/><br/>Headquartered in the Netherlands, the company is a leader in diagnostic imaging, ultrasound, image-guided therapy, monitoring and enterprise informatics, as well as in personal health. Philips generated 2024 sales of EUR 18 billion and employs approximately 67,000 employees with sales and services in more than 100 countries. News about Philips can be found at www.philips.com/newscenter.</p> <p>\n<strong>Attachments</strong>\n</p>\n<ul>\n<li>\nPhilips Verida spectral CT system, angle view\n</li>\n<li>\nPhilips Verida spectral CT system, straight-on view\n</li>\n</ul>\n<br/><img referrerpolicy=\"no-referrer-when-downgrade\" src=\"https://ml-eu.globenewswire.com/media/ODdiNDMyNTUtZGFmMy00MWZlLTgyOTctYzgwOWRkNDY5ZWMzLTEwMTQzNzUtMjAyNS0xMS0zMC1lbg==/tiny/Philips-International-B-V-.png\"/></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4543":"AI","BK4551":"寇图资本持仓","BK4587":"ChatGPT概念","BK4082":"医疗保健设备","BK4528":"SaaS概念","BK4588":"碎股","BK4585":"ETF&股票定投概念","PHG":"飞利浦","BK4023":"应用软件","AI":"C3.ai, Inc."},"source_url":"https://www.globenewswire.com/news-release/2025/11/30/3196599/0/en/Philips-launches-Verida-world-s-first-detector-based-spectral-CT-powered-by-breakthrough-AI-to-advance-diagnostic-precision.html","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2588790413","content_text":"Philips Verida spectral CT system, angle view\n\n\nPhilips Verida spectral CT system, angle view\n\n\nPhilips Verida spectral CT system, straight-on view\n\n\nPhilips Verida spectral CT system, straight-on view\n\nNovember 30, 2025 Philips pioneered detector-based spectral CT, which has been widely adopted in clinical routine exams across anatomies, supported by over 800 peer-reviewed publications [1]CE-marked, 510k pending Verida CT [2] integrates AI across the imaging chain, providing superb image quality while accelerating workflow and reducing dose [3, 4] Amsterdam, the Netherlands and Chicago, USA – At RSNA 2025, Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the launch of Verida, the world’s first detector-based spectral CT fully powered by AI. This marks a transformative milestone in CT, with AI optimizing the entire imaging chain – lowering system noise, elevating image quality, and accelerating clinical workflow. With over 800 global installations and supported by over 800 peer-reviewed publications, Philips’ spectral CT uses PACS-native delivery and has been fully embedded into clinical workflow. Spectral CT measures how tissues absorb different x-ray energy levels, enabling differentiation of materials that appear identical on conventional CT. Philips has pioneered detector-based spectral CT, delivering multiple spectral results from a single scan with no tradeoffs in performance or scan time. Now, by integrating AI across the imaging chain, from acquisition to reconstruction, Philips Verida generates industry-leading, superior spectral image quality with minimal noise, in addition to high-definition conventional images. With its full AI capabilities, Verida can achieve dramatic dose reduction [5] without compromising image quality and reduce energy consumption by up to 45% [6]. “The clinical benefits of Verida will fundamentally change my approach to cardiac imaging,” said Prof. Eliseo Vañó Galván, cardiovascular radiologist, Chairman of the CT & MR Department at Hospital Nuestra. Sra. Del Rosario, Madrid, Spain. “With more comprehensive insights in every cardiac CT, I plan to make spectral imaging routine for all patients – building toward a fully spectral CT department. We evaluated many systems, including photon-counting CT, but chose Philips because it delivers the precision we need in a streamlined, easy-to-use platform. The result is greater diagnostic confidence and the potential to reduce the need for invasive angiograms – not just in cardiology, but across other clinical areas as well [7].” Verida reconstructs 145 images per second, so entire exams automatically appear in less than 30 seconds – 2× faster than before and enabling up to 270 exams every day [8]. Building on Philips’ proprietary Spectral Precise Image technology – a deep learning AI reconstruction engine combined with advanced spectral imaging – and its third-generation Nano-panel Precise dual-layer detector with intrinsic noise reduction optimized for AI, Verida is designed to deliver faster, more dose-efficient spectral reconstructions. This enables clinicians to access rich spectral information from a single scan. “Combining the latest advances in our proven spectral CT technology with AI, our flagship Verida CT system is designed to set a new standard in superior image quality and accelerated scans which are fully embedded in the radiology workflow, all to help clinicians detect and characterize disease earlier, reduce variability in diagnoses, and support efficient treatment pathways – in a single scan,” said Dan Xu, Business Leader of CT at Philips. “While photon-counting CT adds complexity, is yet to move from the research arena into clinical practice, Philips spectral CT has been a clinical workhorse for more than a decade and delivers comparable or better clinical outcomes, standing up to the most demanding throughput and at significantly lower total cost of ownership”. Verida extends Philips’ software-defined CT approach, pairing AI-driven spectral precision to advance both clinical and operational outcomes. Built for high-demand environments, it streamlines workflows, reduces repeat scans, and delivers consistently sharp imaging across all care pathways. Philips is debuting Verida at RSNA 2025, with availability in select markets beginning in 2026 [9]. [1] Data on file.  [2] CE marked and 510(k) pending. Not currently available for sale in the US.[3] Andersen MB et al. Impact of spectral body imaging in patients suspected for occult cancer: a prospective study of 503 patients. Eur Radiol2020. doi.org/10.1007/s00330-020-06878-7[4] Andersen MB et al. Economic impact of spectral body imaging in the diagnosis of patients suspected of occult cancer. Insights into Imaging 2021. doi.org/10.1186/s13244-021-01116-0. Results of customer testimonies are not predictive of results in other cases, where results may vary.[5] Dose reduction assessments were performed using reference body protocol. In clinical practice, the use of Spectral Precise Image may reduce CT patient dose depending on the clinical task, patient size, and anatomical location. A consultation with a radiologist and a physicist should be made to determine the appropriate dose to obtain diagnostic image quality for the particular clinical task. [6] Based on Axial Body 3D Scan with 80% dose reduction. Energy savings for system preparation is not included.[7] Spectral CT Verida Premium up to 270 (4 CIRS config) exams a day (16 hours dual shift working day) meeting the needs of radiology departments with extended work hours and very high patient throughput.[8] The statements of the clinician reflect independent opinion and are not intended to imply product performance prior to regulatory clearance.[9] Pending regulatory clearance. For further information, please contact: Anna HogrebePhilips Global External RelationsTel.: +1 416 270 6757E-mail: anna.hogrebe@philips.com About Royal Philips Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people’s health and well-being through meaningful innovation. Philips’ patient- and people-centric innovation leverages advanced technology and deep clinical and consumer insights to deliver personal health solutions for consumers and professional health solutions for healthcare providers and their patients in the hospital and the home.Headquartered in the Netherlands, the company is a leader in diagnostic imaging, ultrasound, image-guided therapy, monitoring and enterprise informatics, as well as in personal health. Philips generated 2024 sales of EUR 18 billion and employs approximately 67,000 employees with sales and services in more than 100 countries. News about Philips can be found at www.philips.com/newscenter. \nAttachments\n\n\n\nPhilips Verida spectral CT system, angle view\n\n\nPhilips Verida spectral CT system, straight-on view","news_type":1,"symbols_score_info":{"AI":0.86,"PHG":1}},"isVote":1,"tweetType":1,"viewCount":21,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":505771055329416,"gmtCreate":1764487384906,"gmtModify":1764487388713,"author":{"id":"4217035253675822","authorId":"4217035253675822","name":"Sarohiwal","avatar":"https://community-static.tradeup.com/news/2e1ca78599ce252ed2578f03b69bad93","crmLevel":12,"crmLevelSwitch":1,"followedFlag":false,"authorIdStr":"4217035253675822","idStr":"4217035253675822"},"themes":[],"htmlText":"Thanks for sharing, I already invested in this SRS, this is really good investment options","listText":"Thanks for sharing, I already invested in this SRS, this is really good investment options","text":"Thanks for sharing, I already invested in this SRS, this is really good investment options","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/505771055329416","isVote":1,"tweetType":1,"viewCount":91,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":505358403076952,"gmtCreate":1764386775433,"gmtModify":1764386777272,"author":{"id":"4217035253675822","authorId":"4217035253675822","name":"Sarohiwal","avatar":"https://community-static.tradeup.com/news/2e1ca78599ce252ed2578f03b69bad93","crmLevel":12,"crmLevelSwitch":1,"followedFlag":false,"authorIdStr":"4217035253675822","idStr":"4217035253675822"},"themes":[],"title":"","htmlText":"<a href=\"https://ttm.financial/OPT/AMD 20260717 150.0 PUT\">$AMD 20260717 150.0 PUT$</a>&nbsp;","listText":"<a href=\"https://ttm.financial/OPT/AMD 20260717 150.0 PUT\">$AMD 20260717 150.0 PUT$</a>&nbsp;","text":"$AMD 20260717 150.0 PUT$","images":[{"img":"https://community-static.tradeup.com/news/d04b09685e71df81b4844f826331a647","width":"618","height":"1066"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/505358403076952","isVote":1,"tweetType":1,"viewCount":16,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":505358443422376,"gmtCreate":1764386766269,"gmtModify":1764386768591,"author":{"id":"4217035253675822","authorId":"4217035253675822","name":"Sarohiwal","avatar":"https://community-static.tradeup.com/news/2e1ca78599ce252ed2578f03b69bad93","crmLevel":12,"crmLevelSwitch":1,"followedFlag":false,"authorIdStr":"4217035253675822","idStr":"4217035253675822"},"themes":[],"title":"","htmlText":"<a href=\"https://ttm.financial/OPT/AMD 20260717 150.0 PUT\">$AMD 20260717 150.0 PUT$</a>&nbsp;","listText":"<a href=\"https://ttm.financial/OPT/AMD 20260717 150.0 PUT\">$AMD 20260717 150.0 PUT$</a>&nbsp;","text":"$AMD 20260717 150.0 PUT$","images":[{"img":"https://community-static.tradeup.com/news/3311718fe2c6f1aa81ef41e66eeda0b9","width":"618","height":"1066"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/505358443422376","isVote":1,"tweetType":1,"viewCount":38,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":505214860272344,"gmtCreate":1764351695091,"gmtModify":1764351697551,"author":{"id":"4217035253675822","authorId":"4217035253675822","name":"Sarohiwal","avatar":"https://community-static.tradeup.com/news/2e1ca78599ce252ed2578f03b69bad93","crmLevel":12,"crmLevelSwitch":1,"followedFlag":false,"authorIdStr":"4217035253675822","idStr":"4217035253675822"},"themes":[],"title":"","htmlText":"<a href=\"https://ttm.financial/OPT/APLD 20260717 14.0 PUT\">$APLD 20260717 14.0 PUT$</a>&nbsp;","listText":"<a href=\"https://ttm.financial/OPT/APLD 20260717 14.0 PUT\">$APLD 20260717 14.0 PUT$</a>&nbsp;","text":"$APLD 20260717 14.0 PUT$","images":[{"img":"https://community-static.tradeup.com/news/d6a8292e0b5e969ee54740046b02d335","width":"618","height":"1066"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/505214860272344","isVote":1,"tweetType":1,"viewCount":148,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0}],"defaultTab":"following","isTTM":true}